Ocular Histoplasmosis Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2009-08-10
Clinical Trial Update: Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating intravitreal ranibizumab for choroidal neovascularization in ocular histoplasmosis syndrome; latest…